JGC
BMRN icon

J. Goldman & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

J. Goldman & Co’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,300
Closed -$1.67M – 473
2024
Q2 		$1.67M Buy
+20,300
New +$1.69M 0.05% 261
2023
Q3 		– Sell
-17,500
Closed -$1.52M – 374
2023
Q2 		$1.52M Buy
+17,500
New +$1.65M 0.06% 227
2021
Q1 		– Sell
-84,000
Closed -$7.37M – 441
2020
Q4 		$7.37M Buy
+84,000
New +$6.66M 0.37% 78
2016
Q2 		– Sell
-15,000
Closed -$1.24M – 332
2016
Q1 		$1.24M Buy
+15,000
New +$1.22M 0.08% 213

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return